Summit Biosciences Retained to Develop and Supply AT-301 Nasal Spray for Clinical Study

Lane Report

Jun 2, 2020

SEATTLE, May 28, 2020 - Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signif…